John Winslow
Overview
Explore the profile of John Winslow including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Durstenfeld M, Peluso M, Spinelli M, Li D, Hoh R, Chenna A, et al.
J Am Heart Assoc
. 2023 Oct;
12(20):e030896.
PMID: 37830367
Background Postacute sequelae of COVID-19 (PASC) and HIV are both associated with reduced exercise capacity, but whether SARS-CoV-2 or PASC are associated with exercise capacity among people with HIV (PWH)...
2.
Ellis R, Chenna A, Lie Y, Curanovic D, Winslow J, Tang B, et al.
Clin Infect Dis
. 2022 Oct;
76(6):1103-1109.
PMID: 36310512
Background: Neurofilament light (NFL) chain concentrations, reflecting axonal damage, are seen in several polyneuropathies but have not been studied in human immunodeficiency virus (HIV) distal sensory polyneuropathy (DSP). We evaluated...
3.
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment
Ellis R, Chenna A, Petropoulos C, Lie Y, Curanovic D, Crescini M, et al.
J Neurovirol
. 2022 Jun;
28(3):438-445.
PMID: 35674935
We evaluated whether biomarkers of age-related neuronal injury and amyloid metabolism are associated with neurocognitive impairment (NCI) in people with and without HIV (PWH, PWoH). This was a cross-sectional study...
4.
Bauman J, Ohr J, Gooding W, Ferris R, Duvvuri U, Kim S, et al.
Cancers (Basel)
. 2020 Jun;
12(6).
PMID: 32545260
Cetuximab, an anti-EGFR monoclonal antibody (mAb), is approved for advanced head and neck squamous cell carcinoma (HNSCC) but benefits a minority. An established tumor-intrinsic resistance mechanism is cross-talk between the...
5.
Ingersoll J, Moody M, Holland R, Kuegler W, Murrah Jr C, Winslow J, et al.
J Vis Exp
. 2018 Dec;
(141).
PMID: 30507926
The Barnes maze is a reliable measure of spatial learning and memory that does not require food restriction or exposure to extremely stressful stimuli. The Barnes maze can also assess...
6.
Rius Ruiz I, Vicario R, Morancho B, Bernado Morales C, Arenas E, Herter S, et al.
Sci Transl Med
. 2018 Oct;
10(461).
PMID: 30282693
T cell bispecific antibodies (TCBs) are engineered molecules that include, within a single entity, binding sites to the T cell receptor and to tumor-associated or tumor-specific antigens. The receptor tyrosine...
7.
Sperinde J, Huang W, Vehtari A, Chenna A, Kellokumpu-Lehtinen P, Winslow J, et al.
Clin Cancer Res
. 2018 Mar;
24(13):3046-3052.
PMID: 29535130
Expression of p95HER2 (p95), a truncated form of the HER2 receptor, which lacks the trastuzumab binding site but retains kinase activity, has been reported as a prognostic biomarker for poor...
8.
Chumsri S, Sperinde J, Liu H, Gligorov J, Spano J, Antoine M, et al.
Clin Cancer Res
. 2018 Mar;
24(13):3053-3058.
PMID: 29530935
p95HER2 is a truncated form of HER2 that confers resistance to trastuzumab , but clinical results have been conflicting to date. Given that p95HER2 levels correlate with total HER2 expression...
9.
Duchnowska R, Sperinde J, Czartoryska-Arlukowicz B, Mysliwiec P, Winslow J, Radecka B, et al.
Oncotarget
. 2017 Dec;
8(61):104149-104159.
PMID: 29262628
Lapatinib is a HER1 and HER2 tyrosine kinase inhibitor (TKI) approved in second line treatment of advanced or metastatic breast cancer following progression on trastuzumab-containing therapy. Biomarkers for activity of...
10.
Winslow J, Getzin A, Greenberger H, Silbert W
Clin J Sport Med
. 2017 Aug;
29(1):37-42.
PMID: 28817410
Objective: To evaluate the predictive value of fatty infiltrate of the lumbar multifidus muscles (LMM) for return to play in young athletes with extension-based low back pain (EB LBP). Design:...